[Digital Therapy for ADHD: Endeavor Ride and the Current Status and Prospects of Next-Generation Therapeutic Apps].
Digital therapeutics (DTx) for attention-deficit/hyperactivity disorder (ADHD) have emerged as a complementary option to psychosocial interventions. This review focuses on the prescription if video-game therapy EndeavorRx (commercially known as EndeavorRide in Japan), the first game-based DTx approved by the FDA and domestically, and surveys the global development landscape of competing adaptive learning apps and other DTx modalities. We also discuss clinical trial outcomes, effect sizes, safety profiles, and future prospects and explore the potential of personalized DTx approaches.
Authors
- Katsunaka Mikami (ORCID: https://orcid.org/0000-0002-8818-4945)
- Ryo Nishino (ORCID: https://orcid.org/0009-0002-3652-0211)
Institutions
- Kyoto University Hospital (JP)
Publication Details
- Journal
- PubMed
- Published
- 2025-09-01
- DOI
- https://doi.org/10.11477/mf.188160960770091015
- Primary Topic
- Attention Deficit Hyperactivity Disorder
- Type
- article
- Field-Weighted Citation Impact
- 0.00